The involvement of lipoxygenases in inflammatory signalling pathways of human
sebocytes in vitro by Alestas, Theodosios
Medizinische Fakultät der Charité – Universitätsmedizin Berlin 
Campus Benjamin Franklin 
aus der Klinik für Dermatologie, Venerologie und Allergologie 














THE INVOLVEMENT OF LIPOXYGENASES IN 
INFLAMMATORY SIGNALLING PATHWAYS OF  














zur Erlangung der  
medizinischen Doctorwürde 
der Charité – Universitätsmedizin Berlin 










aus Korinth, Griechenland 
 
Referent: Herr Prof. Dr. med. Christos C. Zouboulis 
 
Korreferent: 1. Frau Prof. Dr. med. U. Blume-Peytavi  
                     2. Herr Prof. Dr. med. S. Goerdt 












































Gedrückt mit Genehmigung der Charité – Universitätsmedizin Berlin 




Promoviert am: 15.12.2006 
 
« Τα αγαθά κόποις κτώνται » 
 


























I would like to thank sincerely: 
 
Prof. Dr. med. Prof. Dr. h.c. C.E. Orfanos for the great opportunity he gave me to work at the 
Department of Dermatology, University Medical Center Benjamin Franklin, The Free University 
of Berlin,  
 
Prof. Dr. med. Ch.C. Zouboulis for his full support during my research at his laboratory, 
 
Ms. C. Beutler, Dr. S. Fimmel, Mr. A.M. Hosseini and Dr. P. S. Pattabhiraman for friendly 




1. INTRODUCTION   8 
1.1 The lipoxygenase family   8 
1.2. The metabolism of arachidonic acid   8 
1.3. The P450 mono-oxygenase   9 
1.4. The cyclo-oxygenases   9 
1.5. The 5-lipoxygenase 10 
1.5.1. Purification and amino-sequence 10 
1.5.2. Enzyme location 11 
1.5.3. Catalytic reactions 11 
1.5.4.     Phosphorylation     12 
1.5.5.     5-Lipoxygenase inactivation    12 
1.6.        5-Lipoxygenase activating protein    13 
1.7.        Formation of hydroxy-eicosatetraenoic acids    13 
1.8.        Leukotrienes    13 
1.8.1..    Peptido-leukotrienes    14 
1.9.        Leukotriene A4 hydrolase    14 
1.10.      15-Lipoxygenase    14 
1.10.1.   15-Lipoxygenase-1    15 
1.10.2.   15-Lipoxygenase-2    16 
1.11.      12-Lipoxygenase    17 
1.11.1.   Platelet 12(S)-lipoxygenase    17 
1.11.2.   Leukocyte 12(S)-lipoxygenase    17 
1.11.3.   Epidermal 12(S)-lipoxygenase    18 
1.11.4.   12(R)-lipoxygenase    18 
1.12.      Hepoxilins and lipoxins    18 
1.13.      Biological role of eicosanoids    19 
 
2. AIM OF THE STUDY    22 
 
3. METHODS AND MATERIALS    23 
3.1.        Cell cultures    23 
3.2.        Zileuton extraction    23 
3.3.        Lactate dehydrogenase cytotoxicity assay    24 
3.4.        Protein detection    25 
3.4.1. Cell cultures, treatment and protein extraction    25 
3.4.2. Protein quantitation    26 
3.4.3. Western blot analysis   27 
3.4.4. Membrane stripping and immunoblotting of β-actin   31 
3.5.        RNA detection    31 
3.5.1. Cell culture and treatment    31 
3.5.2. Total RNA isolation    32 
3.5.3. Quantitation of total RNA    33 
3.5.4. Reverse transcription    33 
3.5.5. RT-PCR    34 
3.5.6. Agarose gel electrophoresis   36 
3.6.        Leukotriene B4 enzyme immunoassay    37 
3.7.        Cytokine detection    38 
3.8.        Lipid detection    40 
3.8.1. Nile-red staining    40 
3.8.2. MUH test    41 
3.9.        Immunocytochemical studies    42 
3.9.1. Cytocentrifugation    42 
3.9.2. APAAP    42 
3.10.      Statistical Analysis    44       
 
4. RESULTS    44 
4.1.        Cytotoxicity assay    44 
4.2.        Western blot analysis    45 
4.2.1. β-Actin   45 
4.2.2. 5-Lipoxygenase    45 
4.2.3. 15-Lipoxygenase   47 
4.2.4. LTA4 hydrolase   48 
4.3.        RT-PCR analysis    48 
4.3.1. 5-Lipoxygenase    48 
4.3.2. 15-Lipoxygenase    49 
4.3.3. LTA4 hydrolase    49 
4.4.        5-Lipoxygenase activity    49 
4.5.        Cytokines release    50 
4.5.1. IL-1β    50 
4.5.2. IL-6    50 
4.5.3. IL-8    50 
4.5.4. TNF-α    51 
4.5.5. IL-10 and IL-12(p70)    51 
4.6.        Lipid synthesis    51 
4.6.1. Non-polar lipids    51 
4.6.2. Polar lipids    51 
4.7.        5-Lipoxygenase immunostaining    52 
 
5. DISCUSSION    52 
5.1.        Restrictions and troubles    53 
5.1.1. Treatment of cells   53 
5.1.2. Western blot analysis   54 
5.2.        The skin    55 
5.3.        The sebaceous glands and the sebum    57 
5.4.        SZ95 sebocytes    58 
5.5.        Essential fatty acids    59 
5.6.        5-Lipoxygenase in the skin    59 
5.7.        Leukotriene A4 hydrolase in the skin    61 
5.8.        15-Lipoxygenase in the skin    62 
5.9.        Leukotriene B4 and the skin    65 
5.10.      Peptido-leukotrienes and the skin    67 
5.11.      12-Lipoxygenase in the skin    67 
5.12.      Cyclo-oxygenase in the skin    67 
5.13.      P450 mono-oxygenase in the skin    68 
5.14.      PPARs and the skin    68 
5.15.      Cytokines and lipoxygenases    71 
5.16.      Involvement of eicosanoids in skin diseases    73 
5.16.1. Psoriasis    73 
5.16.2. Atopic dermatitis    75 
5.16.3. Systemic sclerosis    76 
5.16.4. Acne vulgaris    77 
5.17.      Lipoxygenase inhibitors    80 
5.17.1. Zileuton    82 
5.17.2. Lipoxygenase inhibitors and skin diseases    82 
 
6. CONCLUSION    84 
 
7. FIGURES    88 
 
8. REFERENCES    102 
 
CURRICULUM VITAE    113 
ABBREVIATIONS 
 
• 5-HPETE = 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid 
• 5-LOX = 5-lipoxygenase (EC 1.13.11.34) 
• 12-HPETE=12-hydroperoxy-5,8,10,14-eicosatetraenoic acid 
• 12-LOX = 12-lipoxygenase (EC 1.13.11.31) 
• 15-HPETE=15-hydroperoxy-5,8,11,13-eicosatetraenoic acid 
• 15-LOX = 15-lipoxygenase (EC 1.13.11.33) 
• AA = arachidonic acid 
• AD = atopic dermatitis 
• APAAP = alkaline phosphatase anti-alkaline phosphatase 
• bp = base pair 
• CaI = calcium ionophore A23187 
• Caf = caffeic acid 
• DEPC = diethyl pyrocarbonate 
• DHA = docosahexaenoic acid 
• DMSO = dimethyl sulfoxide 
• EIA = enzyme immuno assay 
• EPA = eicosapentanoic acid 
• ETYA = 5,8,11,14-eicosatetraynoic acid 
• FBS = fetal bovine serum 
• FFA = free fatty acid 
• FLAP = 5-lipoxygenase activating protein 
• Gus = glucuronidase 
• HETE = hydroxy-eicosatetraenoic acid 
• IL = interleukin 
• kDa = kilodalton 
• LA = linoleic acid 
• LDH = lactate dehydrogenase 
• LTA4 hydrolase = leukotriene A4 hydrolase (EC 3.3.26) 
• LTA4 = 5,6-trans-oxido-7,9-trans-11,14-cis-eicosatetraenoic acid 
• LTB4 = 5,12-dihydroxy-8,10-trans-6,14-cis-eicosatetraenoic acid 
• LTC4 = 5-hydroxy-6-glutathionyl-7,9-trans-11,14-cis-eicosatetraenoic acid 
• LTD4 = 5-hydroxy-6-cysteinylglycyl-7,9-trans-11,14-cis-eicosatetraenoic acid 
• LTE4 = 5-hydroxy-6-cysteinyl-7,9-trans-11,14-cis-eicosatetraenoic acid 
• NDGA = nordihydroguaiaretic acid 
• NLS = nuclear localization signal 
• PBS = phosphate buffered saline 
• PG = prostaglandin 
• PLA = phospholipase A 
• PPAR = peroxisome proriferator-activated receptor 
• PVDF = polyvinylidene fluoride paper 
• RT-PCR = reverse transcriptase polymerase chain reaction 
• SS = systemic sclerosis 
• TNF-α = tumor necrosis factor-α 
• UVB = ultra-violet B 
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